This message was sent to ##Email##
To advertise in this publication please click here
|
|
|
.FSP NEWS
Legislative Update from FSP Lobbyist Amy Young
FSP
The results from the election on Nov. 3, 2020 show that the current Republican majority in the State Senate and State House will be maintained in Florida. Official certification of the election results will take place on Nov. 17, 2020. FSP lobbyist Amy Young has summarized a complete list of the results for the state of Florida. To read the full report please visit the FSP website here.
|
|
FSP — Now Accepting Posters for Poster Hall
FSP
The FSP is now accepting posters for inclusion in the FSP Virtual Poster Hall in conjunction with the upcoming 47th Annual Pathology Conference taking place virtually on Feb. 12-14, 2021. All pathologists are invited to submit a poster. Residents and Fellows can submit a poster for inclusion in the Poster Competition and for a chance to present during a Platform Presentation. The deadline to submit is Jan. 8, 2021. To learn more and to submit your poster visit the FSP website.
|
|
FSP Virtual Membership Business Meeting on Dec. 3 — Register Now
FSP
The FSP will host a Virtual Membership Business Meeting on Thursday, Dec. 3 at 7 p.m. ET. During the webinar, members will hear from FSP leadership on the state of the society, including updates on membership, announcements regarding the upcoming FSP Conference in February and our new virtual format, and an FSP bylaws update which will require a member vote. To review the meeting agenda and the proposed updates to the FSP bylaws visit the FSP website here. To reserve your space, register online here.
|
|
|
|
.INDUSTRY NEWS
Promising interim results from clinical trial of NIH-Moderna COVID-19 vaccine
NIH
An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial oversight group on Nov. 15, 2020. This interim review of the data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults.
|
|
|
|
 |
|
Our Anatomical and Clinical Pathology Billing expertise maximizes collections for practices nationwide.
Click here to find out if YOUR billing is optimized!
|
|
'Next-gen' immunotherapy active in advanced cancers
MedPage Today
share to facebook
share to twitter
share to linkedin
email article
An investigational drug that combines PD-1/L1 inhibition and T-cell stimulation led to disease control in two-thirds of patients with unresectable advanced solid malignancies, a preliminary clinical study showed.
Overall, 40 of 61 previously treated patients achieved disease control with GEN1046, including four partial responses. Initial efficacy data from an expansion cohort of patients with relapsed/refractory non-small cell lung cancer showed that seven of 12 patients achieved disease control, including three partial responses.
|
|
Treatments for people with early COVID-19 infection is an urgent research focus
NIH
COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, M.D., and colleagues. Treating people early in the course of infection with SARS-CoV-2, the virus that causes COVID-19, would speed their recovery, reduce the likelihood that they develop severe outcomes and reduce demand on the healthcare system, they write.
|
|
Existing antidepressant helps to inhibit growth of cancer cells in lab animals
EurekAlert
New research has shown that the antidepressant sertraline helps to inhibit the growth of cancer cells. The substance acts on a metabolic addiction that allows different types of cancer to grow. This is shown by a study on cell cultures and lab animals performed by various research labs of KU Leuven. Their findings were published in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
|
|
New 3D cell culture method could enable personalized cancer therapies
Drug Target Review
A new three-dimensional (3D) cell culture technique may enable the personalised treatment of cancer by allowing researchers to understand the contributions of different cell types in a tumour.
The study was conducted at Purdue University, US. The team say they are the first to demonstrate a 3D cell culture made from individually selected cells.
|
|
Beaumont study shows how well masks work at stopping COVID-19 transmission
Detroit Free Press
Wearing a mask protects people from contracting the novel coronavirus, according to a new study by the Beaumont Research Institute of employees, which was published earlier this month in the Journal of Clinical Infectious Diseases.
The study showed that of the 20,614 Beaumont health care workers who took part in the research, 1,818 — or 8.8% — had developed SARS-CoV-2 antibodies on serology blood tests.
That means 91.2% did not contract the virus despite working in health care-related jobs through the first COVID-19 surge in Michigan, when more than 1,200 COVID-19 inpatients were admitted in the health system's eight hospitals.
|
|
2020 has seen AI emerge as essential to disease research
AI in Healthcare News
The COVID crisis has given AI a chance to shine for medical researchers this year—and shine it has, judging by one prominent center’s experience.
Starting in March, “many of us dropped all other research and tried to focus entirely on doing COVID modeling,” Jayashree Kalpathy-Cramer, PhD, recalls.
|
|
Turning the problem of cancer metastasis into an opportunity
Technology Networks
When a patient with cancer is told the devastating news that their disease has spread, or metastasized, to a new part of their body, it has most often moved to their lungs. The branching blood vessels that allow oxygen to diffuse from the lungs' air sacs into red blood cells are so tiny that a rogue cancer cell circulating in the bloodstream can easily get stuck there and take up residence, eventually growing into a secondary tumor. Once established, metastatic tumors unleash a campaign of chemical cues that thwart the body's defenses, hampering efforts to induce an immune response. There are no treatments approved for lung metastasis, which is the leading cause of death from metastatic disease.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
